ATC code A07 - A07AA Antibiotics. A07AA01 Neomycin A07AA02 Nystatin A07AA03 Natamycin A07AA04 Streptomycin A07AA05 Polymyxin B A07AA06 Paromomycin A07AA07 Amphotericin B A07AA08 Kanamycin A07AA09 Vancomycin A07AA10 Colistin A07AA11 Rifaximin A07AA51 Neomycin, combinations A07AA54 Streptomycin, combinations ATC code A07 - A07AB Sulfonamides. A07AB02 Phthalylsulfathiazole A07A ...

See also:

ATC code A07, ATC code A07 - A07A Intestinal anti-infectives, ATC code A07 - A07AA Antibiotics, ATC code A07 - A07AB Sulfonamides, ATC code A07 - A07AC Imidazole derivatives, ATC code A07 - A07AX Other intestinal anti-infectives, ATC code A07 - A07B Intestinal adsorbents, ATC code A07 - A07BA Charcoal preparations, ATC code A07 - A07BB Bismuth preparations, ATC code A07 - A07BC Other intestinal adsorbents, ATC code A07 - A07C Electrolytes with carbohydrates, ATC code A07 - A07CA Oral rehydration salt formulations, ATC code A07 - A07D Antipropulsives, ATC code A07 - A07DA Antipropulsives, ATC code A07 - A07E Intestinal anti-inflammatory agents, ATC code A07 - A07EA Corticosteroids acting locally, ATC code A07 - A07EB Antiallergic agents excluding corticosteroids, ATC code A07 - A07EC Aminosalicylic acid and similar agents, ATC code A07 - A07F Antidiarrheal micro-organisms, ATC code A07 - A07FA Antidiarrheal micro-organisms, ATC code A07 - A07X Other antidiarrheals, ATC code A07 - A07XA Other antidiarrheals

Read more here: » ATC code A07: Encyclopedia II - ATC code A07 - A07A Intestinal anti-infectives

ATC code A07 - A07BA Charcoal preparations. A07BA01 Medicinal charcoal A07BA51 Medicinal charcoal, combinations ATC code A07 - A07BB Bismuth preparations. ATC code A07 - A07BC Other intestinal adsorbents. A07BC01 Pectin A07BC02 Kaolin A07BC03 Crospovidone A07BC04 Attapulgite A07BC05 Diosmectite A07BC30 Combinations A07BC54 Attapulgite, combinations ...

See also:

ATC code A07, ATC code A07 - A07A Intestinal anti-infectives, ATC code A07 - A07AA Antibiotics, ATC code A07 - A07AB Sulfonamides, ATC code A07 - A07AC Imidazole derivatives, ATC code A07 - A07AX Other intestinal anti-infectives, ATC code A07 - A07B Intestinal adsorbents, ATC code A07 - A07BA Charcoal preparations, ATC code A07 - A07BB Bismuth preparations, ATC code A07 - A07BC Other intestinal adsorbents, ATC code A07 - A07C Electrolytes with carbohydrates, ATC code A07 - A07CA Oral rehydration salt formulations, ATC code A07 - A07D Antipropulsives, ATC code A07 - A07DA Antipropulsives, ATC code A07 - A07E Intestinal anti-inflammatory agents, ATC code A07 - A07EA Corticosteroids acting locally, ATC code A07 - A07EB Antiallergic agents excluding corticosteroids, ATC code A07 - A07EC Aminosalicylic acid and similar agents, ATC code A07 - A07F Antidiarrheal micro-organisms, ATC code A07 - A07FA Antidiarrheal micro-organisms, ATC code A07 - A07X Other antidiarrheals, ATC code A07 - A07XA Other antidiarrheals

Read more here: » ATC code A07: Encyclopedia II - ATC code A07 - A07B Intestinal adsorbents

ATC code A07 - A07DA Antipropulsives. A07DA01 Diphenoxylate A07DA02 Opium A07DA03 Loperamide A07DA04 Difenoxin A07DA05 Loperamide oxide A07DA52 Morphine, combinations A07DA53 Loperamide, combinations ...

See also:

ATC code A07, ATC code A07 - A07A Intestinal anti-infectives, ATC code A07 - A07AA Antibiotics, ATC code A07 - A07AB Sulfonamides, ATC code A07 - A07AC Imidazole derivatives, ATC code A07 - A07AX Other intestinal anti-infectives, ATC code A07 - A07B Intestinal adsorbents, ATC code A07 - A07BA Charcoal preparations, ATC code A07 - A07BB Bismuth preparations, ATC code A07 - A07BC Other intestinal adsorbents, ATC code A07 - A07C Electrolytes with carbohydrates, ATC code A07 - A07CA Oral rehydration salt formulations, ATC code A07 - A07D Antipropulsives, ATC code A07 - A07DA Antipropulsives, ATC code A07 - A07E Intestinal anti-inflammatory agents, ATC code A07 - A07EA Corticosteroids acting locally, ATC code A07 - A07EB Antiallergic agents excluding corticosteroids, ATC code A07 - A07EC Aminosalicylic acid and similar agents, ATC code A07 - A07F Antidiarrheal micro-organisms, ATC code A07 - A07FA Antidiarrheal micro-organisms, ATC code A07 - A07X Other antidiarrheals, ATC code A07 - A07XA Other antidiarrheals

Read more here: » ATC code A07: Encyclopedia II - ATC code A07 - A07D Antipropulsives

ATC code A07 - A07FA Antidiarrheal micro-organisms. A07FA01 Lactic acid producing organisms A07FA02 Saccharomyces boulardii A07FA51 Lactic acid producing organisms, combinations ...

See also:

ATC code A07, ATC code A07 - A07A Intestinal anti-infectives, ATC code A07 - A07AA Antibiotics, ATC code A07 - A07AB Sulfonamides, ATC code A07 - A07AC Imidazole derivatives, ATC code A07 - A07AX Other intestinal anti-infectives, ATC code A07 - A07B Intestinal adsorbents, ATC code A07 - A07BA Charcoal preparations, ATC code A07 - A07BB Bismuth preparations, ATC code A07 - A07BC Other intestinal adsorbents, ATC code A07 - A07C Electrolytes with carbohydrates, ATC code A07 - A07CA Oral rehydration salt formulations, ATC code A07 - A07D Antipropulsives, ATC code A07 - A07DA Antipropulsives, ATC code A07 - A07E Intestinal anti-inflammatory agents, ATC code A07 - A07EA Corticosteroids acting locally, ATC code A07 - A07EB Antiallergic agents excluding corticosteroids, ATC code A07 - A07EC Aminosalicylic acid and similar agents, ATC code A07 - A07F Antidiarrheal micro-organisms, ATC code A07 - A07FA Antidiarrheal micro-organisms, ATC code A07 - A07X Other antidiarrheals, ATC code A07 - A07XA Other antidiarrheals

Read more here: » ATC code A07: Encyclopedia II - ATC code A07 - A07F Antidiarrheal micro-organisms

Iatrogenic Cushing's syndrome (caused by treatment with corticosteroids) is the most common form of Cushing's syndrome. Endogenous (i.e. non-iatrogenic) Cushing's syndrome is relatively rare. Incidence of causes of Cushing's syndrome per million person-years: Cushing's disease: 10 Primary adrenal: 3 Ectopic ACTH: 1.4 ...

See also:

Cushing's syndrome, Cushing's syndrome - Signs and symptoms, Cushing's syndrome - Diagnosis, Cushing's syndrome - Pathophysiology, Cushing's syndrome - Therapy, Cushing's syndrome - Epidemiology, Cushing's syndrome - Reference

Read more here: » Cushing's syndrome: Encyclopedia II - Cushing's syndrome - Epidemiology

ATC code C05 - C05BA Heparins or heparinoids for topical use. C05BA01 Organo-heparinoid C05BA02 Sodium apolate C05BA03 Heparin C05BA04 Pentosan polysulfate sodium C05BA51 Heparinoid, combinations C05BA53 Heparin, combinations ATC code C05 - C05BB Sclerosing agents for local injection. C05BB01 Monoethanolamine oleate C05BB02 Polidocanol C05BB03 Invert sugar C05BB04 Sodium tetradecyl sulfate C0 ...

See also:

ATC code C05, ATC code C05 - C05A Antihemorrhoidals for topical use, ATC code C05 - C05AA Products containing corticosteroids, ATC code C05 - C05AB Products containing antibiotics, ATC code C05 - C05AD Products containing local anesthetics, ATC code C05 - C05AX Other antihemorrhoidals for topical use, ATC code C05 - C05B Antivaricose therapy, ATC code C05 - C05BA Heparins or heparinoids for topical use, ATC code C05 - C05BB Sclerosing agents for local injection, ATC code C05 - C05BX Other sclerosing agents, ATC code C05 - C05C Capillary stabilising agents, ATC code C05 - C05CA Bioflavonoids, ATC code C05 - C05CX Other capillary stabilising agents

Read more here: » ATC code C05: Encyclopedia II - ATC code C05 - C05B Antivaricose therapy

Acute respiratory distress syndrome - Historical background. Acute respiratory distress syndrome was first described in 1967 by Ashbaugh et al.[1] Initially there was no definition, resulting in controversy over incidence and mortality. In 1988 an expanded definition ...

See also:

Acute respiratory distress syndrome, Acute respiratory distress syndrome - Definition, Acute respiratory distress syndrome - Historical background, Acute respiratory distress syndrome - Consensus after 1967 and 1994, Acute respiratory distress syndrome - Patient presentation and diagnosis, Acute respiratory distress syndrome - Pathophysiology, Acute respiratory distress syndrome - Inflammation, Acute respiratory distress syndrome - Mechanical stress, Acute respiratory distress syndrome - Progression, Acute respiratory distress syndrome - Treatment, Acute respiratory distress syndrome - General, Acute respiratory distress syndrome - Mechanical ventilation, Acute respiratory distress syndrome - Positive end-expiratory pressure, Acute respiratory distress syndrome - Prone position, Acute respiratory distress syndrome - Fluid management, Acute respiratory distress syndrome - Corticosteroids, Acute respiratory distress syndrome - Nitric oxide, Acute respiratory distress syndrome - Surfactant therapy, Acute respiratory distress syndrome - Complications, Acute respiratory distress syndrome - Epidemiology

Read more here: » Acute respiratory distress syndrome: Encyclopedia II - Acute respiratory distress syndrome - Definition

ARDS usually occurs within 24 to 48 hours of the initial injury or illness. The patient usually presents with shortness of breath, tachypnea, and symptoms related to the underlying cause, i.e. shock. An arterial blood gas analysis and chest X-ray allow formal diagnosis by inference using the aforementioned criteria. Although severe hypoxemia is generally included, the appropriate threshold defining abnormal PaO2 has never been systematically studied. Any cardiogenic cause of pulmonary edema must sometimes be excluded. This is done by placing a pulmonary ar ...

See also:

Acute respiratory distress syndrome, Acute respiratory distress syndrome - Definition, Acute respiratory distress syndrome - Historical background, Acute respiratory distress syndrome - Consensus after 1967 and 1994, Acute respiratory distress syndrome - Patient presentation and diagnosis, Acute respiratory distress syndrome - Pathophysiology, Acute respiratory distress syndrome - Inflammation, Acute respiratory distress syndrome - Mechanical stress, Acute respiratory distress syndrome - Progression, Acute respiratory distress syndrome - Treatment, Acute respiratory distress syndrome - General, Acute respiratory distress syndrome - Mechanical ventilation, Acute respiratory distress syndrome - Positive end-expiratory pressure, Acute respiratory distress syndrome - Prone position, Acute respiratory distress syndrome - Fluid management, Acute respiratory distress syndrome - Corticosteroids, Acute respiratory distress syndrome - Nitric oxide, Acute respiratory distress syndrome - Surfactant therapy, Acute respiratory distress syndrome - Complications, Acute respiratory distress syndrome - Epidemiology

Read more here: » Acute respiratory distress syndrome: Encyclopedia II - Acute respiratory distress syndrome - Patient presentation and diagnosis

ARDS is characterized by a diffuse inflammation of lung parenchyma. The triggering insult to the parenchyma usually results in an initial release of cytokines and other inflammatory mediators, secreted by local epithelial and endothelial cells. Neutrophils and some T-lymphocytes quickly migrate into the inflamed lung parynchema and contribute in the amplification of the phenomenon. Typical histological presentation involves diffuse alveolar damage and hyaline membrane formation in alveolar walls. Although the triggering mechanisms are not completely understood, recen ...

See also:

Acute respiratory distress syndrome, Acute respiratory distress syndrome - Definition, Acute respiratory distress syndrome - Historical background, Acute respiratory distress syndrome - Consensus after 1967 and 1994, Acute respiratory distress syndrome - Patient presentation and diagnosis, Acute respiratory distress syndrome - Pathophysiology, Acute respiratory distress syndrome - Inflammation, Acute respiratory distress syndrome - Mechanical stress, Acute respiratory distress syndrome - Progression, Acute respiratory distress syndrome - Treatment, Acute respiratory distress syndrome - General, Acute respiratory distress syndrome - Mechanical ventilation, Acute respiratory distress syndrome - Positive end-expiratory pressure, Acute respiratory distress syndrome - Prone position, Acute respiratory distress syndrome - Fluid management, Acute respiratory distress syndrome - Corticosteroids, Acute respiratory distress syndrome - Nitric oxide, Acute respiratory distress syndrome - Surfactant therapy, Acute respiratory distress syndrome - Complications, Acute respiratory distress syndrome - Epidemiology

Read more here: » Acute respiratory distress syndrome: Encyclopedia II - Acute respiratory distress syndrome - Pathophysiology

Acute respiratory distress syndrome - General. Acute respiratory distress syndrome is usually treated with mechanical ventilation in the Intensive Care Unit. Ventilation is usually delivered through oro-tracheal intubation, or tracheostomy whenever prolonged ventilation (≥2 weeks) is deemed inevitable. The possibilities of non-invasive ventilation are limited to the very early period of the disease or, better, to prevention in individuals at risk for the development of the disease (atypical pneumonias, pulmonary contusion, major surgery patients). Treatment of the underlyi ...

See also:

Acute respiratory distress syndrome, Acute respiratory distress syndrome - Definition, Acute respiratory distress syndrome - Historical background, Acute respiratory distress syndrome - Consensus after 1967 and 1994, Acute respiratory distress syndrome - Patient presentation and diagnosis, Acute respiratory distress syndrome - Pathophysiology, Acute respiratory distress syndrome - Inflammation, Acute respiratory distress syndrome - Mechanical stress, Acute respiratory distress syndrome - Progression, Acute respiratory distress syndrome - Treatment, Acute respiratory distress syndrome - General, Acute respiratory distress syndrome - Mechanical ventilation, Acute respiratory distress syndrome - Positive end-expiratory pressure, Acute respiratory distress syndrome - Prone position, Acute respiratory distress syndrome - Fluid management, Acute respiratory distress syndrome - Corticosteroids, Acute respiratory distress syndrome - Nitric oxide, Acute respiratory distress syndrome - Surfactant therapy, Acute respiratory distress syndrome - Complications, Acute respiratory distress syndrome - Epidemiology

Read more here: » Acute respiratory distress syndrome: Encyclopedia II - Acute respiratory distress syndrome - Treatment

Acute respiratory distress syndrome - Historical background. Acute respiratory distress syndrome was first described in 1967 by Ashbaugh et al.[2] Initially there was no definition, resulting in controversy over incidence and mortality. In 1988 an expanded definition ...

See also:

Acute respiratory distress syndrome, Acute respiratory distress syndrome - Definition, Acute respiratory distress syndrome - Historical background, Acute respiratory distress syndrome - Consensus after 1967 and 1994, Acute respiratory distress syndrome - Patient presentation and diagnosis, Acute respiratory distress syndrome - Pathophysiology, Acute respiratory distress syndrome - Inflammation, Acute respiratory distress syndrome - Mechanical stress, Acute respiratory distress syndrome - Progression, Acute respiratory distress syndrome - Treatment, Acute respiratory distress syndrome - General, Acute respiratory distress syndrome - Mechanical ventilation, Acute respiratory distress syndrome - Positive end-expiratory pressure, Acute respiratory distress syndrome - Prone position, Acute respiratory distress syndrome - Fluid management, Acute respiratory distress syndrome - Corticosteroids, Acute respiratory distress syndrome - Nitric oxide, Acute respiratory distress syndrome - Surfactant therapy, Acute respiratory distress syndrome - Complications, Acute respiratory distress syndrome - Epidemiology

Read more here: » Acute respiratory distress syndrome: Encyclopedia II - Acute respiratory distress syndrome - Definition

ATC code N02 - N02BA Salicylic acid and derivatives. N02BA01 Acetylsalicylic acid N02BA02 Aloxiprin N02BA03 Choline salicylate N02BA04 Sodium salicylate N02BA05 Salicylamide N02BA06 Salsalate N02BA07 Ethenzamide N02BA08 Morpholine salicylate N02BA09 Dipyrocetyl N02BA10 Benorilate N02BA11 Diflunisal N02BA12 Potassium salicylate N02BA14 Guacetisal N02BA15 Carbasalate calcium N02BA16 Im ...

See also:

ATC code N02, ATC code N02 - N02A Opioids, ATC code N02 - N02AA Natural opium alkaloids, ATC code N02 - N02AB Phenylpiperidine derivatives, ATC code N02 - N02AC Diphenylpropylamine derivatives, ATC code N02 - N02AD Benzomorphan derivatives, ATC code N02 - N02AE Oripavine derivatives, ATC code N02 - N02AF Morphinan derivatives, ATC code N02 - N02AG Opioids in combination with antispasmodics, ATC code N02 - N02AX Other opioids, ATC code N02 - N02B Other analgesics and antipyretics, ATC code N02 - N02BA Salicylic acid and derivatives, ATC code N02 - N02BB Pyrazolones, ATC code N02 - N02BE Anilides, ATC code N02 - N02BG Other analgesics and antipyretics, ATC code N02 - N02C Antimigraine preparations, ATC code N02 - N02CA Ergot alkaloids, ATC code N02 - N02CB Corticosteroid derivatives, ATC code N02 - N02CC Selective serotonin 5-HT1 agonists, ATC code N02 - N02CX Other antimigraine preparations

Read more here: » ATC code N02: Encyclopedia II - ATC code N02 - N02B Other analgesics and antipyretics

ATC code N02 - N02AA Natural opium alkaloids. N02AA01 Morphine N02AA02 Opium N02AA03 Hydromorphone N02AA04 Nicomorphine N02AA05 Oxycodone N02AA08 Dihydrocodeine N02AA09 Diamorphine N02AA10 Papaveretum N02AA51 Morphine, combinations N02AA58 Dihydrocodeine, combinations N02AA59 Codeine, combinations excluding psycholeptics N02AA79 Co ...

See also:

ATC code N02, ATC code N02 - N02A Opioids, ATC code N02 - N02AA Natural opium alkaloids, ATC code N02 - N02AB Phenylpiperidine derivatives, ATC code N02 - N02AC Diphenylpropylamine derivatives, ATC code N02 - N02AD Benzomorphan derivatives, ATC code N02 - N02AE Oripavine derivatives, ATC code N02 - N02AF Morphinan derivatives, ATC code N02 - N02AG Opioids in combination with antispasmodics, ATC code N02 - N02AX Other opioids, ATC code N02 - N02B Other analgesics and antipyretics, ATC code N02 - N02BA Salicylic acid and derivatives, ATC code N02 - N02BB Pyrazolones, ATC code N02 - N02BE Anilides, ATC code N02 - N02BG Other analgesics and antipyretics, ATC code N02 - N02C Antimigraine preparations, ATC code N02 - N02CA Ergot alkaloids, ATC code N02 - N02CB Corticosteroid derivatives, ATC code N02 - N02CC Selective serotonin 5-HT1 agonists, ATC code N02 - N02CX Other antimigraine preparations

Read more here: » ATC code N02: Encyclopedia II - ATC code N02 - N02A Opioids

ATC code S01 - S01AA Antibiotics. S01AA01 Chloramphenicol S01AA02 Chlortetracycline S01AA03 Neomycin S01AA04 Oxytetracycline S01AA05 Tyrothricin S01AA07 Framycetin S01AA09 Tetracycline S01AA10 Natamycin S01AA11 Gentamicin S01AA12 Tobramycin S01AA13 Fusidic acid S01AA14 Benzylpenicillin S01AA15 Dihydrostreptomycin S01AA16 Rifamycine S01AA17 Erythromycin S01AA18 Polymyxin BSee also:

ATC code S01, ATC code S01 - S01A Anti-infectives, ATC code S01 - S01AA Antibiotics, ATC code S01 - S01AB Sulphonamides, ATC code S01 - S01AD Antivirals, ATC code S01 - S01AX Other anti-infectives, ATC code S01 - S01B Anti-inflammatory agents, ATC code S01 - S01BA Corticosteroids plain, ATC code S01 - S01BB Corticosteroids and mydriatics in combination, ATC code S01 - S01BC Anti-inflammatory agents non-steroids, ATC code S01 - S01C Anti-inflammatory agents and anti-infectives in combination, ATC code S01 - S01CA Corticosteroids and anti-infectives in combination, ATC code S01 - S01CB Corticosteroids/anti-infectives/mydriatics in combination, ATC code S01 - S01CC Anti-inflammatory agents non-steroids and anti-infectives in combination, ATC code S01 - S01E Antiglaucoma preparations and miotics, ATC code S01 - S01EA Sympathomimetics in glaucoma therapy, ATC code S01 - S01EB Parasympathomimetics, ATC code S01 - S01EC Carbonic anhydrase inhibitors, ATC code S01 - S01ED Beta blocking agents, ATC code S01 - S01EE Prostaglandin analogues, ATC code S01 - S01EX Other antiglaucoma preparations, ATC code S01 - S01F Mydriatics and cycloplegics, ATC code S01 - S01FA Anticholinergics, ATC code S01 - S01FB Sympathomimetics excluding antiglaucoma preparations, ATC code S01 - S01G Decongestants and antiallergics, ATC code S01 - S01GA Sympathomimetics used as decongestants, ATC code S01 - S01GX Other antiallergics, ATC code S01 - S01H Local anesthetics, ATC code S01 - S01HA Local anesthetics, ATC code S01 - S01J Diagnostic agents, ATC code S01 - S01JA Colouring agents, ATC code S01 - S01JX Other ophthalmological diagnostic agents, ATC code S01 - S01K Surgical aids, ATC code S01 - S01KA Viscoelastic substances, ATC code S01 - S01KX Other surgical aids, ATC code S01 - S01X Other ophthalmologicals, ATC code S01 - S01XA Other ophthalmologicals

Read more here: » ATC code S01: Encyclopedia II - ATC code S01 - S01A Anti-infectives

Possible side effects are varied, and range from fever and nausea to major allergic reactions. One of the more common side effects is diarrhea, which results from the antibiotic disrupting the normal balance of intestinal flora. Other side effects can result from interaction with other drugs, such as elevated risk of tendon damage from administration of a quinolone antibiotic with a systemic corticosteroid. Some antibiotics can interfere with the efficacy of birth control pills. Such effects were found to be unusual, and have been studie ...

See also:

Antibiotic, Antibiotic - History, Antibiotic - Classes of Antibiotics, Antibiotic - Production, Antibiotic - Side effects, Antibiotic - Antibiotic misuse, Antibiotic - Antibiotic resistance, Antibiotic - Beyond antibiotics

Read more here: » Antibiotic: Encyclopedia II - Antibiotic - Side effects

Initial treatment is generally with corticosteroids and oral cyclophosphamide (CYC), 1 mg/kg/day and 2 mg/kg/day respectively. Occasionally CYC is given in monthly IV doses. Monitoring of the white blood count is essential during CYC therapy. Once remission is attained (normally 3 to 6 months), treatment is frequently changed to azathioprine or methotrexate, which are less toxic drugs. Total duration of therapy should be at least 1 year, or longer in high risk patients. Corticosteroids are tapered to a low maintenance dose, 5-10 mg/day. Plasmapherisis may be beneficial in severe disease or pulmonary hemorrhage. E ...

See also:

Wegener's granulomatosis, Wegener's granulomatosis - Signs and symptoms, Wegener's granulomatosis - Diagnosis, Wegener's granulomatosis - Criteria, Wegener's granulomatosis - Pathophysiology, Wegener's granulomatosis - Treatment, Wegener's granulomatosis - Epidemiology, Wegener's granulomatosis - Prognosis, Wegener's granulomatosis - History

Read more here: » Wegener's granulomatosis: Encyclopedia II - Wegener's granulomatosis - Treatment

Pregnenolone undergoes further steroid metabolism in one of two ways. Pregnenolone can be converted to progesterone. The critical enzyme step is two-fold using a 3-beta-hydroxysteroid dehydrogenase and a delta 4-5 isomerase. The latter transfers the double bond from C5 to C4 on the A ring. Progesterone is the entry into the delta-4-pathway resulting in production of 17-hydroxy progesterone, and androstenedione, precursor to testosterone and estrone. Aldosterone and corticosteroids are also derived f ...

See also:

Pregnenolone, Pregnenolone - Chemistry, Pregnenolone - Synthesis, Pregnenolone - Prohormone, Pregnenolone - Neurosteroid

Read more here: » Pregnenolone: Encyclopedia II - Pregnenolone - Prohormone

Spacers are tubes attached to the inhaler that act as a reservoir or holding chamber. They serve to hold the medication that is sprayed by the inhaler. This makes it easier to use the inhaler and helps ensure that more of the medication gets into the lungs instead of just into the mouth or the air. With proper use, a spacer can make an inhaler 20 percent more effective in delivering medicine. Spacers can be especially helpful to adults and children who find a regular inhaler hard to use. People who use corticosteroid inhaler ...

See also:

Metered dose inhaler, Metered dose inhaler - Benefits of MDIs, Metered dose inhaler - Proper use of a MDI, Metered dose inhaler - Spacers, Metered dose inhaler - When does an inhaler need to be replaced?

Read more here: » Metered dose inhaler: Encyclopedia II - Metered dose inhaler - Spacers

The causative mechanisms are poorly understood but involve complex neurological and vascular factors. Priapism may be associated with prolonged sexual activity, leukaemia, Fabry's disease, haematological disorders (such as sickle-cell disease), cerebrospinal disease (such as syphilis), genital infection, some spinal injuries, or inflammation (Beers & Berkow, 1999). Priapism can be caused by drugs such as certain antidepressants, antihypertensives, anticoagulants and corticosteroids. It can also be a withdrawal symptom of drugs such as heroin. Priapism is often present in spinal inj ...

See also:

Priapism, Priapism - Causes, Priapism - Complications, Priapism - Treatment, Priapism - Miscellaneous

Read more here: » Priapism: Encyclopedia II - Priapism - Causes

The main cause is insulin resistance, which explains co-occurrence of NASH and syndrome X. NASH can also be caused by the following medications: Amiodarone Antiviral drugs (nucleoside analogues) Aspirin / NSAIDS Corticosteroids Methotrexate Nifedipine Perhexiline maleate Tamoxifen Tetracycline Valproic acid ...

See also:

Non-alcoholic steatohepatitis, Non-alcoholic steatohepatitis - Signs and symptoms, Non-alcoholic steatohepatitis - Laboratory imaging and diagnosis, Non-alcoholic steatohepatitis - Causes, Non-alcoholic steatohepatitis - Treatment, Non-alcoholic steatohepatitis - History

Read more here: » Non-alcoholic steatohepatitis: Encyclopedia II - Non-alcoholic steatohepatitis - Causes

Many forms of severe stress and trauma, stroke, heart attack, and surgery can temporarily increase glucose levels. Glycemia can also be increased by certain drugs such as antidepressants, corticosteroids, diuretics, estrogens, lithium, phenotiazine, phenytoin and salicilates; or decreased by others, such as acetaminophen, alcohol, steroids, clofibrate, gemfibrozil, etc. However, the disease most directly associated to chronic increase of glycemia is diabetes mellitus, due to a decrease in the secretion of insulin, excess of its breakdown or decreased capacity of cells to transport i ...

See also:

Glycemia, Glycemia - Physiological regulation, Glycemia - Measurement, Glycemia - Abnormal values

Read more here: » Glycemia: Encyclopedia II - Glycemia - Abnormal values

Rejection is prevented with a combination of drugs including: Calcineurin inhibitors Cyclosporine Tacrolimus mTOR inhibitors Sirolimus Everolimus Anti-proliferatives Azathioprine Mycophenolate mofetil Corticosteroids Prednisolone Hydrocortisone Antibodies Monoclonal anti-IL-2Rα receptor antibodies Basiliximab Dacl ...

See also:

Transplant rejection, Transplant rejection - Types of rejection, Transplant rejection - Hyperacute rejection, Transplant rejection - Acute rejection, Transplant rejection - Chronic rejection, Transplant rejection - Prevention of rejection, Transplant rejection - Treatment of rejection

Read more here: » Transplant rejection: Encyclopedia II - Transplant rejection - Prevention of rejection